{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:26:28Z","timestamp":1782483988360,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The purpose of this study was to investigate pain and radiological features of different types of first-episode demyelinating optic neuritis (ON).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighty-three patients presenting with first-episode aquaporin-4 (AQP4) antibody-associated ON (AQP4-ON; <jats:italic>n<\/jats:italic> = 28), myelin oligodendrocyte glycoprotein (MOG) antibody-associated ON (MOG-ON; <jats:italic>n<\/jats:italic> = 26) and idiopathic demyelinating optic neuritis (IDON, <jats:italic>n<\/jats:italic> = 29) were included in this retrospective case-control study. We assessed optic nerve lesions on magnetic resonance imaging (MRI), acute pain associated with onset of optic neuritis and clinical characteristics of those ON patients with different serum autoantibody status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>24 AQP4-ON patients (85.75%), 23 MOG-ON patients (88.5%) and 24 IDON patients (82.8%) suffered from ON-associated pain. MOG-ON had mostly retro-orbital pain; AQP4-ON and IDON had mostly neuropathic pain. In addition, pain was more severe in AQP4ON patients than in other ON patients. In MRI, bilateral involvement was more common in AQP4-ON than IDON (26.9 and 3.7%); radiological optic nerve head swelling was more common in MOG-ON than in AQP4-ON and IDON (68.0 vs. 23.1 vs. 25.9%). MRI lesion in peri-optic nerve sheath was more common in AQP4-ON (53.8 vs. 16.0 vs. 3.7%). In 70 patients with ON-associated pain, gadolinium enhancement of orbital optic nerve was most common in MOG-ON patients (82.4 vs. 55.0 vs. 33.3%, <jats:italic>P<\/jats:italic> = 0.018), and enhancement of optic chiasma was most common in AQP4-ON patients (40.0 vs. 5.9 vs. 6.7%, <jats:italic>P<\/jats:italic> = 0.015). Perineural and orbital enhancement was observed only in patients with MOG-ON (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The length of enhancement was longer in AQP4-ON patients than in MOG-ON and IDON patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pain is a common symptom in patients with all types of demyelinating ON. AQP4-ON is frequently associated with severe ON-associated pain and longitudinally extensive optic nerve inflammatory lesions. Intra-orbital and peri-optic inflammation were more frequently observed in patients with MOG-ON, which was closely related to optic disc swelling and retro-orbital pain provoked by eye movements.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2022.870211","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T07:10:18Z","timestamp":1652080218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON"],"prefix":"10.3389","volume":"3","author":[{"given":"Hao","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"experience of the optic neuritis treatment trial. optic neuritis study group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.autrev.2014.01.009","article-title":"Diagnosis and classification of autoimmune optic neuropathy","volume":"13","author":"Petzold","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1212\/WNL.0000000000002840","article-title":"Trigeminal neuralgia: new classification and diagnostic grading for practice and research","volume":"87","author":"Cruccu","year":"2016","journal-title":"Neurology."},{"key":"B4","first-page":"1","article-title":"headache classification committee of the international headache society","volume":"8","year":"1988","journal-title":"Cephalalgia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","year":"2018","journal-title":"Cephalalgia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-2982.2003.00824.x","article-title":"The int:ernational classification of headache disorders: 2nd edition","volume":"24","year":"2004","journal-title":"Cephalalgia."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","article-title":"Migraine: disease characterisation, biomarkers, and precision medicine","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Deneve","year":"2019","journal-title":"J Neuroradiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/08820538.2020.1866027","article-title":"MRI Characteristics of NMO, MOG and MS related optic neuritis","volume":"35","author":"Winter","year":"2020","journal-title":"Semin Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult scler"},{"key":"B11","doi-asserted-by":"publisher","first-page":"s75","DOI":"10.1007\/s10072-005-0413-y","article-title":"Controversies in optic neuritis pain diagnosis","volume":"2","author":"Agostoni","year":"2005","journal-title":"Neurol sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0161-6420(03)00477-9","article-title":"Optic neuritis: correlation of pain and magnetic resonance imaging","volume":"110","author":"Fazzone","year":"2003","journal-title":"Ophthalmology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica\u2013prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2055217318796684","DOI":"10.26226\/morressier.5b719e455aff74008ae4ccc0","article-title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","volume":"4","author":"Asseyer","year":"2018","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat Rev Neurosc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/ACO.0b013e32830c900c","article-title":"Acute neuropathic pain: diagnosis and treatment","volume":"21","author":"Gray","year":"2008","journal-title":"Curr Opin Anaesthesiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/brain\/awf087","article-title":"Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance","volume":"125","author":"Kupersmith","year":"2002","journal-title":"Brain J Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10072-018-3334-1","article-title":"Pain in optic neuropathies","volume":"39","author":"Marzoli","year":"2018","journal-title":"Neurol sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3988\/jcn.2020.16.1.124","article-title":"Comparison of neuropathic pain in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"16","author":"Hyun","year":"2020","journal-title":"J Clin Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1083\/jcb.201504106","article-title":"The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry","volume":"210","author":"von Budingen","year":"2015","journal-title":"J Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.msard.2020.101965","article-title":"Prodromal headache in MOG-antibody positive optic neuritis","volume":"40","author":"Asseyer","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat Rev Neurosc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1172\/JCI134816","article-title":"Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"616301","DOI":"10.3389\/fimmu.2021.616301","article-title":"The emerging role of microglia in neuromyelitis optica","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/imt-2018-0153","article-title":"The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain","volume":"11","author":"Robinson","year":"2019","journal-title":"Immunotherapy."},{"key":"B29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbi.2020.07.001","article-title":"Glial cell activation and altered metabolic profile in the spinal-trigeminal axis in a rat model of multiple sclerosis associated with the development of trigeminal sensitization","volume":"89","author":"Magni","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/brain\/awab231","article-title":"MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response","volume":"144","author":"Pellerin","year":"2021","journal-title":"Brain J Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2012.10.037","article-title":"Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain","volume":"77","author":"Simonetti","year":"2013","journal-title":"Neuron."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1523\/JNEUROSCI.2018-07.2007","article-title":"Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity","volume":"27","author":"Griffin","year":"2007","journal-title":"J Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","article-title":"Association of neuromyelitis optica with severe and intractable pain","volume":"69","author":"Qian","year":"2012","journal-title":"Arch Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin."}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.870211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T07:10:20Z","timestamp":1652080220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2022.870211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":35,"alternative-id":["10.3389\/fpain.2022.870211"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2022.870211","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"article-number":"870211"}}